| Disclosure of Compensation Related Costs, Share-based Payments [Text Block] |
Note 6 – Equity Incentive Plans
General
DCT’s share-based awards are long-term retention plans that are intended to attract, retain and provide incentives for talented employees. DCT believes its share-based awards are critical to its operation and productivity. The employee share-based award plans allow DCT to grant, on a discretionary basis, incentive stock options and non-qualified stock options.
The following table sets forth, by the respective option plan, certain aspects of DCT’s stock options as of March 31, 2012:
| |
|
Option Approval Method |
|
|
Options Outstanding and Options Available |
|
| Description |
|
Board of Directors |
|
|
Board of Directors and Shareholders |
|
|
Total |
|
|
Outstanding |
|
|
Available For Future Grant |
|
|
Total |
|
| 2002 Amended and Restated Stock Option Plan |
|
|
– |
|
|
|
3,200,000 |
|
|
|
3,200,000 |
|
|
|
2,478,710 |
|
|
|
721,290 |
|
|
|
3,200,000 |
|
| 2006 Stock Option Plan |
|
|
– |
|
|
|
2,500,000 |
|
|
|
2,500,000 |
|
|
|
2,299,000 |
|
|
|
201,000 |
|
|
|
2,500,000 |
|
| 2009 Stock Option Plan |
|
|
– |
|
|
|
1,500,000 |
|
|
|
1,500,000 |
|
|
|
1,179,333 |
|
|
|
320,667 |
|
|
|
1,500,000 |
|
| 2010 Stock Option Plan |
|
|
– |
|
|
|
3,500,000 |
|
|
|
3,500,000 |
|
|
|
2,500,000 |
|
|
|
1,000,000 |
|
|
|
3,500,000 |
|
| Key Personnel Option Grants |
|
|
7,875,000 |
|
|
|
– |
|
|
|
7,875,000 |
|
|
|
5,917,315 |
|
|
|
– |
|
|
|
5,917,315 |
|
| |
|
|
7,875,000 |
|
|
|
10,700,000 |
|
|
|
18,575,000 |
|
|
|
14,374,358 |
|
|
|
2,242,957 |
|
|
|
16,617,315 |
|
Stock Options
DCT issues options under four different stock option plans as well as through employment agreements with key employees, executives and consultants (approved by the board of directors on a case-by-case basis). Options generally vest over two to three years from the date of grant and expire seven to ten years from the date of grant.
Stock-Based Compensation
The following table sets forth the total stock-based compensation expense included in DCT’s Statements of Operations (in thousands):
| |
|
Three Months
Ended March 31, |
|
| |
|
2012 |
|
|
2011 |
|
| Selling, general and administrative |
|
$ |
233 |
|
|
$ |
291 |
|
| Research and development |
|
|
14 |
|
|
|
31 |
|
| |
|
$ |
247 |
|
|
$ |
322 |
|
At March 31, 2012, DCT had approximately $692,000 of total unrecognized compensation cost related to unvested stock options. This cost is expected to be recognized over a weighted-average period of approximately one year.
Stock Option Activity and Outstanding
DCT had the following stock option activity during the three months ended March 31, 2012:
| |
|
Options |
|
|
Weighted- Average Exercise Price |
|
| Outstanding at December 31, 2011 |
|
|
14,524,358 |
|
|
$ |
0.34 |
|
| Granted |
|
|
- |
|
|
|
- |
|
| Cancelled |
|
|
50,000 |
|
|
|
0.32 |
|
| Exercised |
|
|
100,000 |
|
|
|
0.01 |
|
| Outstanding at March 31, 2012 |
|
|
14,374,358 |
|
|
$ |
0.35 |
|
| Vested or expected to vest at March 31, 2012 |
|
|
14,374,358 |
|
|
$ |
0.35 |
|
The following table summarizes all options outstanding and exercisable by price range as of March 31, 2012:
| |
|
|
Options Outstanding |
|
|
Options Exercisable |
|
|
Range of Exercise Prices
|
|
|
Number
Outstanding
|
|
|
Weighted- Average Remaining Contractual Life (Years) |
|
|
Weighted-
Average
Exercise Price
|
|
|
Number
Exercisable
|
|
|
Weighted- Average
Exercise Price
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| $ |
0.01 |
|
|
|
2,042,315 |
|
|
|
0.1 |
|
|
$ |
0.01 |
|
|
|
2,042,315 |
|
|
$ |
0.01 |
|
| $ |
0.29-$0.45 |
|
|
|
9,432,043 |
|
|
|
5.9 |
|
|
$ |
0.32 |
|
|
|
5,884,214 |
|
|
$ |
0.32 |
|
| $ |
0.60 - $0.70 |
|
|
|
2,900,000 |
|
|
|
6.6 |
|
|
$ |
0.68 |
|
|
|
2,200,000 |
|
|
$ |
0.68 |
|
| |
|
|
|
|
14,374,358 |
|
|
|
|
|
|
|
|
|
|
|
10,126,529 |
|
|
|
|
|
The “intrinsic value” of options is the excess of the value of DCT stock over the exercise price of such options. The total intrinsic value of options outstanding (of which all are expected to vest) at March 31, 2012 was approximately $1,081,000. The total intrinsic value of options outstanding at December 31, 2011 was $1,546,000. The total intrinsic value for exercisable options was $953,000 and $1,303,000 at March 31, 2012 and December 31, 2011, respectively. The total intrinsic value was $27,000 for options exercised during the three months ended March 31, 2012. |